Bar graphs showing overall distribution of [a] HIV-1 drug resistance (HIVDR) variants by time points and drug classes, and [b] genotypic susceptibility of pre-treatment HIVDR variants detected by next generation sequencing from HIV infected antiretroviral-naïve individuals in a rural clinic in Coastal Kenya (n = 50)$.</p
With a national prevalence of 4.9% in the adult population, the HIV-1 epidemic in Kenya is the fifth...
Genotypic drug resistance testing has been an integral part of the clinical management of HIV patien...
Background: The emergence and spread of antiretroviral drug resistant HIV-1 variants is one of the m...
BackgroundThe epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequencin...
Background The epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequenci...
Characteristics and distribution of participants with HIV-1 pre-treatment drug resistance variants d...
BackgroundThe epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequencin...
Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve a...
HIV was first described in Kenya in 1984-1985. Currently, Kenya has an estimated HIV-1 prevalence of...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
The development of resistance mutations in drug-targeted HIV-1 genes compromises the success of anti...
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (T...
<div><p>HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Sahara...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
With a national prevalence of 4.9% in the adult population, the HIV-1 epidemic in Kenya is the fifth...
Genotypic drug resistance testing has been an integral part of the clinical management of HIV patien...
Background: The emergence and spread of antiretroviral drug resistant HIV-1 variants is one of the m...
BackgroundThe epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequencin...
Background The epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequenci...
Characteristics and distribution of participants with HIV-1 pre-treatment drug resistance variants d...
BackgroundThe epidemiology of HIV-1 drug resistance (HIVDR) determined by Sanger capillary sequencin...
Distribution of HIV-1 transmitted drug resistance mutations amongst antiretroviral treatment naïve a...
HIV was first described in Kenya in 1984-1985. Currently, Kenya has an estimated HIV-1 prevalence of...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (TDR) are ess...
The development of resistance mutations in drug-targeted HIV-1 genes compromises the success of anti...
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug resistance (T...
<div><p>HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Sahara...
HIV-1 transmitted drug resistance (TDR) is of increasing public health concern in sub-Saharan Africa...
With a national prevalence of 4.9% in the adult population, the HIV-1 epidemic in Kenya is the fifth...
Genotypic drug resistance testing has been an integral part of the clinical management of HIV patien...
Background: The emergence and spread of antiretroviral drug resistant HIV-1 variants is one of the m...